Skip to content
Research/Regenerative Aesthetics/Poly-L-Lactic Acid (Sculptra) Injection

Poly-L-Lactic Acid (Sculptra) Injection

Poly-L-Lactic Acid (Sculptra) is an injectable dermal filler used primarily in cosmetic procedures to stimulate collagen production and restore facial volume. Its mechanism involves the gradual thickening of the skin as collagen is rebuilt, which can contribute to a more youthful appearance and potentially support skin health as part of longevity and health optimization strategies.

Intelligence Profile

Research Papers

Research on Poly-L-Lactic Acid (PLLA) injections has been focused on its safety, effectiveness, and various aesthetic applications. Below is a synthesis of key studies and clinical trials:

  1. Management of PLLA Nodules: A scoping review published in Cureus (2026) explores the development of nodules post-PLLA injection and maps a clinical pathway for managing these occurrences, highlighting safety concerns that need attention.

  2. Cellulite Improvement: A study in the Journal of Drugs in Dermatology (JDD, 2026) assesses the safety and effectiveness of PLLA-SCA for cellulite improvement, showing favorable outcomes for patients seeking cosmetic enhancements.

  3. Décolletage Wrinkles: Another JDD article (2026) examines different reconstitution volumes of PLLA for décolletage wrinkle correction, indicating that variations in preparation can influence outcomes.

  4. Arm Contouring: A trial published in Frontiers in Surgery (2026) compares Rennova® Elleva and Sculptra® for arm contouring. This prospective, blinded study indicates promising results for non-surgical arm improvement.

  5. Patient Satisfaction and Clinical Outcomes: A randomized, comparative study in the Journal of Cosmetic Dermatology (2026) evaluates patient satisfaction with PLLA treatments, showing generally positive outcomes regarding aesthetic results and satisfaction.

  6. Injection Procedure Safety: The Cureus journal (2026) introduces the BioMold template to enhance safety and precision in PLLA injections, potentially reducing complications and improving injector confidence.

  7. Nasolabial Folds Correction: A double-blind trial in Aesthetic Plastic Surgery (2026) examines Gana V PLLA for nasolabial folds, demonstrating non-inferiority to existing treatments, thus validating its effectiveness.

  8. Midface Transition Softening: The JDD (2025) reports that PLLA-SCA effectively softens the transition between the lower eyelid and midface, providing an option for subtle facial improvements.

Clinical trials further support PLLA's diverse applications. For instance:

  • Midface Improvement Study (NCT05963204): This trial evaluates PLLA paired with skincare for midface enhancement, yielding completed results but lacking detailed outcomes in the provided evidence.

  • Acne Scarring and Skin Laxity: Trials like NCT00795327 and NCT03487172 show completed investigations into PLLA for acne scarring and knee skin laxity, respectively, suggesting a broadening application scope.

In summary, the research reflects PLLA's versatility and general safety in cosmetic dermatology, though precise technique and patient selection remain crucial for optimal results.

Disclaimer: This summary is for informational purposes only and not a substitute for professional medical advice.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.